Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).
BACKGROUND
Antiarrhythmic agents have modest efficacy in preventing atrial fibrillation (AF) recurrence. Although retrospective analyses have suggested a preventive effect of inhibitors of the renin-angiotensin system (RAS) on AF development in patients with congestive heart failure or hypertension, the value of these agents has not been evaluated in patients with AF but without a high prevalence of hypertension or heart failure.


RESULTS
A retrospective analysis of the Canadian Trial of Atrial Fibrillation (CTAF) was conducted. CTAF demonstrated the superiority of amiodarone (A) over sotalol or propafenone (SP) in maintaining sinus rhythm in patients with AF. Of the 403 patients randomly assigned in CTAF, 11.7% of the A group and 12.7% of the SP group were receiving a RAS inhibitor at baseline. By multivariate analysis (including all the risk factors known to be associated with AF available in the database), the use of RAS blockers in addition to antiarrhythmic agents was not associated with additional benefit against AF development. There was a recurrence of AF in 59 patients (38.3%) and 14 patients (29.8%) of groups A and A-RAS, respectively, while 93 patients (61.6%) and 32 patients (62.8%) of the SP and SP-RAS groups, respectively, experienced recurrent AF.


CONCLUSIONS
Blocking the RAS did not provide additional benefit against AF recurrence in CTAF patients treated with an antiarrhythmic drug. These results underscore the need for randomized clinical trials to clearly define the role of RAS inhibitors in treating AF.
Palardy
Maryse
M
Department of Medicine, Montreal Heart Institute, Montreal, Canada.
Ducharme
Anique
A
Nattel
Stanley
S
Tardif
Jean-Claude
JC
White
Michel
M
Racine
Normand
N
Tétreault
Karine
K
Dabouz
Farida
F
Talajic
Mario
M
Roy
Denis
D
D000368:Aged; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002170:Canada; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011405:Propafenone / Q000627:therapeutic use; D011446:Prospective Studies; D012084:Renin-Angiotensin System / Q000187:drug effects*; D055502:Secondary Prevention; D013015:Sotalol / Q000627:therapeutic use; D000092502:Renin Inhibitors
D000638:Amiodarone; D000889:Anti-Arrhythmia Agents; D011405:Propafenone; D013015:Sotalol; D000092502:Renin Inhibitors
Circulation. 1999 Jul 6;100(1):87-95
10393686
Int J Cardiol. 2005 Dec 7;105(3):315-8
16274775
Eur Heart J. 2006 Aug;27(15):1841-6
16825288
JAMA. 1994 Mar 16;271(11):840-4
8114238
Can J Cardiol. 2004 Oct;20(12):1245-8
15494777
J Am Coll Cardiol. 2000 May;35(6):1669-77
10807475
Cardiovasc Res. 1999 Oct;44(1):121-31
10615396
Circulation. 1996 Dec 1;94(11):2968-74
8941128
J Am Coll Cardiol. 2005 Jun 7;45(11):1832-9
15936615
Circulation. 1997 Nov 18;96(10):3710-20
9396475
J Am Coll Cardiol. 2003 Jun 18;41(12):2197-204
12821247
J Pharmacol Toxicol Methods. 1999 Sep;42(1):11-20
10715599
Am Heart J. 2006 Jul;152(1):86-92
16838426
Heart Rhythm. 2004 Nov;1(5):531-7
15851214
Am Heart J. 2005 Mar;149(3):548-57
15864246
N Engl J Med. 2000 Mar 30;342(13):913-20
10738049
Circ Res. 1997 Oct;81(4):512-25
9314832
J Am Coll Cardiol. 2005 Mar 1;45(5):712-9
15734615
Circulation. 2003 Jun 17;107(23):2926-31
12771010
Circulation. 1996 Oct 1;94(7):1600-6
8840850
Circulation. 2001 Nov 20;104(21):2608-14
11714658
Circulation. 1997 Aug 19;96(4):1180-4
9286947
Circulation. 2000 Jun 6;101(22):2612-7
10840013
Circulation. 1997 Oct 7;96(7):2455-61
9337224
Circulation. 2002 Jul 16;106(3):331-6
12119249
Circ Res. 1997 Dec;81(6):1045-52
9400386
Am J Cardiol. 2001 Oct 15;88(8):906-9, A8
11676961
Circulation. 2004 Aug 31;110(9):1042-6
15313941
Pacing Clin Electrophysiol. 2004 Oct;27(10):1405-10
15511250
Cardiovasc Res. 2002 May;54(2):230-46
12062329
Am J Cardiol. 1991 Aug 1;68(4):335-41
1907089
Circulation. 1995 Mar 1;91(5):1588-95
7867201
Circulation. 1999 Jul 27;100(4):376-80
10421597
Heart Rhythm. 2004 Dec;1(6):669-75
15851238
Circulation. 1995 Oct 1;92(7):1954-68
7671380